11+ urlaubsantrag muster kostenlos

Thursday, November 22nd 2018. | Vorlage Beispiel
11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

11+ urlaubsantrag muster kostenlos

urlaubsantrag muster kostenlos

NASHUA, N.H., Dec. 27, 2018 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a all-around medical technology aggregation accouterment avant-garde blight apprehension and analysis solutions, today appear that Richard Christopher, Controlling Vice President, Chief Banking Officer, is resigning from the Aggregation to accompany addition career opportunity, able January 11, 2019. Mr. Christopher’s abandonment is not the aftereffect of any altercation or altercation with iCAD or any amount apropos to the Company’s accounting practices or banking statements. iCAD’s Board of Directors has accustomed the arrangement of R. Scott Areglado, Vice President and Corporate Controller, to the position of acting Chief Banking Officer. The Aggregation will conduct an controlling chase action to analyze a almsman to Mr. Christopher.

“Scott has served as iCAD’s Corporate Controller for added than seven years, and has ahead captivated the role of acting Chief Banking Officer,” said Michael Klein, Controlling Chairman and CEO. “We are awful assured in his adeptness to baby-sit our banking operations. Importantly, accepting aloof bankrupt a $7.0 actor clandestine adjustment to be activated primarily to abutment added bartering activities for our afresh FDA austere ProFound AI for mammography, a high-performance, blight apprehension AI technology, iCAD is in a able banking position.”

Mr. Areglado has served as Vice President and Corporate Controller back May 2011, and ahead captivated the role of acting Chief Banking Officer from September 2016 to November 2016, above-mentioned to the arrangement of Mr. Christopher in November 2016. From 2005 to 2010, Mr. Areglado served as Vice President and Controller at AMICAS, Inc., a NASDAQ-listed angel and advice administration solutions aggregation confined the healthcare industry, area he led the banking account alertness and accounting operations for the company, including abutment for the acknowledged accretion of the aggregation by Merge Healthcare. Mr. Areglado has added than 25 years of acquaintance in accounts and accounting and was a Certified Accessible Accountant from 1990 to 2007. Mr. Areglado accustomed a Master of Business Administration amount from the Franklin W. Olin Graduate School of Business at Babson College and a Bachelor of Business Administration amount in Accounting from the University of Massachusetts, Amherst.

“On account of the iCAD team, I would like to acknowledge Rich for his adherence to the Aggregation as CFO, and ambition him success in his approaching endeavors,” connected Mr. Klein.

About iCAD, Inc.

Headquartered in Nashua, NH, iCAD is a all-around medical technology baton accouterment avant-garde blight apprehension and analysis solutions. For added information, Media

“Safe Harbor” Account beneath the Clandestine Securities Action Reform Act of 1995

Certain statements independent in this News Absolution aggregate “forward-looking statements” aural the acceptation of the Clandestine Securities Action Reform Act of 1995. Such advanced statements absorb a cardinal of accepted and alien risks, uncertainties and added factors which may account the absolute results, achievement or achievements of the Aggregation to be materially altered from any approaching results, achievement or achievements bidding or adumbrated by such advanced statements. Such factors include, but are not bound to the Company’s adeptness to avert itself in action matters, to accomplish business and cardinal objectives, the risks of ambiguity of apparent protection, the appulse of accumulation and accomplishment constraints or difficulties, ambiguity of approaching sales levels, aegis of patents and added proprietary rights, artefact bazaar acceptance, accessible abstruse obsolescence of products, added competition, action and/or government regulation, changes in Medicare or added agreement policies, risks apropos to our absolute and approaching debt obligations, aggressive factors, the furnishings of a abatement in the abridgement or markets served by the Company; and added risks abundant in the Company’s filings with the Securities and Exchange Commission. The words “believe”, “demonstrate”, “intend”, “expect”, “would”, “could”, “consider”, “project”, “estimate”, “will”, “continue”, “anticipate”, “likely”, “seek”, and agnate expressions analyze advanced statements. Readers are cautioned not to abode disproportionate assurance on those advanced statements, which allege alone as of the date the account was made. The Aggregation is beneath no obligation to accommodate any updates to any advice independent in this release. For added acknowledgment apropos these and added risks faced by iCAD, amuse see the acknowledgment independent in our accessible filings with the Securities and Exchange Commission, including the 10-K for the year concluded December 31, 2017, accessible on the Investors area of our website Media on the SEC’s website at http://www.sec.gov.

Contact:

Media Inquiries:

ARPR, on account of iCAD, Inc.
Paul Barren, 1 (855) Media

Investor Relations:
LifeSci Advisors
Jeremy Feffer, 1 (212) Media